- Home
- TMUS vs NVS Comparison
TMUS vs NVS Comparison
Compare TMUS & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMUS
- NVS
- Stock Information
- Founded
- TMUS 1994
- NVS 1895
- Country
- TMUS United States
- NVS Switzerland
- Employees
- TMUS N/A
- NVS N/A
- Industry
- TMUS Telecommunications Equipment
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- TMUS Telecommunications
- NVS Health Care
- Exchange
- TMUS Nasdaq
- NVS Nasdaq
- Market Cap
- TMUS 285.3B
- NVS 230.5B
- IPO Year
- TMUS N/A
- NVS 1991
- Fundamental
- Price
- TMUS $221.52
- NVS $115.78
- Analyst Decision
- TMUS Buy
- NVS Hold
- Analyst Count
- TMUS 21
- NVS 6
- Target Price
- TMUS $257.48
- NVS $123.67
- AVG Volume (30 Days)
- TMUS 4.5M
- NVS 1.2M
- Earning Date
- TMUS 07-30-2025
- NVS 07-17-2025
- Dividend Yield
- TMUS 1.59%
- NVS 3.45%
- EPS Growth
- TMUS 39.35
- NVS N/A
- EPS
- TMUS 10.25
- NVS 6.38
- Revenue
- TMUS $82,692,000,000.00
- NVS $53,222,000,000.00
- Revenue This Year
- TMUS $8.30
- NVS $7.22
- Revenue Next Year
- TMUS $5.05
- NVS $1.94
- P/E Ratio
- TMUS $21.61
- NVS $18.14
- Revenue Growth
- TMUS 5.31
- NVS 11.50
- 52 Week Low
- TMUS $173.74
- NVS $96.06
- 52 Week High
- TMUS $276.49
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- TMUS 30.19
- NVS 51.61
- Support Level
- TMUS $220.00
- NVS $117.71
- Resistance Level
- TMUS $231.61
- NVS $120.92
- Average True Range (ATR)
- TMUS 3.94
- NVS 1.12
- MACD
- TMUS -1.72
- NVS -0.34
- Stochastic Oscillator
- TMUS 5.52
- NVS 8.87
About TMUS T-Mobile US Inc.
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 80 million postpaid and 25 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 7 million residential and business customers. In addition, T-Mobile provides wholesale services to resellers.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.